Authors:
GOBERT A
RIVET JM
AUDINOT V
NEWMANTANCREDI A
CISTARELLI L
MILLAN MJ
Citation: A. Gobert et al., SIMULTANEOUS QUANTIFICATION OF SEROTONIN, DOPAMINE AND NORADRENALINE LEVELS IN SINGLE FRONTAL-CORTEX DIALYSATES OF FREELY-MOVING RATS REVEALS A COMPLEX PATTERN OF RECIPROCAL AUTO-MEDIATED AND HETERORECEPTOR-MEDIATED CONTROL OF RELEASE, Neuroscience, 84(2), 1998, pp. 413-429
Citation: Mj. Millan et al., SEROTONIN (5-HT)(2C) RECEPTORS TONICALLY INHIBIT DOPAMINE (DA) AND NORADRENALINE (NA), BUT NOT 5-HT, RELEASE IN THE FRONTAL-CORTEX IN-VIVO, Neuropharmacology, 37(7), 1998, pp. 953-955
Authors:
MILLAN MJ
NEWMANTANCREDI A
BROCCO N
GOBERT A
LEJEUNE F
AUDINOT V
RIVET JM
SCHREIBER R
DEKEYNE A
SPEDDING M
NICOLAS JP
PEGLION JL
Citation: Mj. Millan et al., S-18126 4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)PIPERAZIN-1-YL METHYL]INDAN-2-YL)), A POTENT, SELECTIVE AND COMPETITIVE ANTAGONIST AT DOPAMINE D-4 RECEPTORS - AN IN-VITRO AND IN-VIVO COMPARISON WITH L-745,870 YL]PIPERAZIN-1-YL)METHYL-1H-PYRROLO[2,3B]PYRIDINE) AND RACLOPRIDE, The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 167-186
Authors:
AUDINOT V
NEWMANTANCREDI A
GOBERT A
RIVET JM
BROCCO M
LEJEUNE F
GLUCK L
DESPOSTE I
BERVOETS K
DEKEYNE A
MILLAN MJ
Citation: V. Audinot et al., A COMPARATIVE IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL DOPAMINE D-3 RECEPTOR ANTAGONISTS (-S-14297, NAFADOTRIDE, GR-103,691 AND U-99194()), The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 187-197
Authors:
MILLAN MJ
GOBERT A
NEWMANTANCREDI A
AUDINOT V
LEJEUNE F
RIVET JM
CUSSAC D
NICOLAS JP
MULLER O
LAVIELLE G
Citation: Mj. Millan et al., S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL, The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1341-1355
Authors:
MILLAN MJ
BROCCO M
VEIGA S
CISTARELLI L
MELON C
GOBERT A
Citation: Mj. Millan et al., WAY-100,635 ENHANCES BOTH THE ANTIDEPRESSANT ACTIONS OF DULOXETINE AND ITS INFLUENCE ON DIALYSATE LEVELS OF SEROTONIN IN FRONTAL-CORTEX, European journal of pharmacology, 341(2-3), 1998, pp. 165-167
Authors:
MILLAN MJ
NEWMANTANCREDI A
RIVET JM
BROCCO M
LACROIX P
AUDINOT V
CISTARELLI L
GOBERT A
Citation: Mj. Millan et al., S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .1. INTERACTION WITH CLONED HUMAN (H)5-HT1A, DOPAMINE HD(2) HD(3) AND H-ALPHA(2A)-ADRENERGIC RECEPTORS IN RELATION TO MODULATION OF CORTICAL MONOAMINE RELEASE AND ACTIVITY IN MODELS OF POTENTIAL ANTIDEPRESSANT ACTIVITY/, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 132-147
Authors:
GOBERT A
RIVET JM
CISTARELLI L
MELON C
MILLAN MJ
Citation: A. Gobert et al., ALPHA(2)-ADRENERGIC RECEPTOR BLOCKADE MARKEDLY POTENTIATES DULOXETINE-INDUCED AND FLUOXETINE-INDUCED INCREASES IN NORADRENALINE, DOPAMINE, AND SEROTONIN LEVELS IN THE FRONTAL-CORTEX OF FREELY MOVING RATS, Journal of neurochemistry, 69(6), 1997, pp. 2616-2619
Citation: A. Gobert et al., POTENTIATION OF THE FLUOXETINE-INDUCED INCREASE IN DIALYSATE LEVELS OF SEROTONIN (5-HT) IN THE FRONTAL-CORTEX OF FREELY MOVING RATS BY COMBINED BLOCKADE OF 5-HT1A AND 5-HT1B RECEPTORS WITH WAY-100,635 AND GR-127,935, Journal of neurochemistry, 68(3), 1997, pp. 1159-1163
Citation: A. Gobert et al., BUSPIRONE ENHANCES DULOXETINE-INDUCED AND FLUOXETINE-INDUCED INCREASES IN DIALYSATE LEVELS OF DOPAMINE AND NORADRENALINE, BUT NOT SEROTONIN, IN THE FRONTAL-CORTEX OF FREELY MOVING RATS, Journal of neurochemistry, 68(3), 1997, pp. 1326-1329
Authors:
NEWMANTANCREDI A
AUDINOTBOUCHEZ V
GOBERT A
MILLAN MJ
Citation: A. Newmantancredi et al., NORADRENALINE AND ADRENALINE ARE HIGH-AFFINITY AGONISTS AT DOPAMINE D-4 RECEPTORS, European journal of pharmacology, 319(2-3), 1997, pp. 379-383
Citation: Mj. Millan et A. Gobert, AUTORECEPTOR AND HETEROCEPTOR CONTROL OF 5-HT, DOPAMINE (DA) AND NORADRENALINE (NAD) RELEASE IN FRONTAL-CORTEX - STRATEGIES FOR IMPROVED ANTIDEPRESSANT AGENTS, British Journal of Pharmacology, 122, 1997, pp. 468-468
Authors:
HUBER A
SANDER P
GOBERT A
BAHNER M
HERMANN R
PAULSEN R
Citation: A. Huber et al., THE TRANSIENT RECEPTOR POTENTIAL PROTEIN (TRP), A PUTATIVE STORE-OPERATED CA2-MEDIATED PHOTORECEPTION, FORMS A SIGNALING COMPLEX WITH NORPA, INAC AND INAD( CHANNEL ESSENTIAL FOR PHOSPHOINOSITIDE), EMBO journal, 15(24), 1996, pp. 7036-7045
Authors:
GOBERT A
LEJEUNE F
RIVET JM
CISTARELLI L
MILLAN MJ
Citation: A. Gobert et al., DOPAMINE D-3 (AUTO) RECEPTORS INHIBIT DOPAMINE RELEASE IN THE FRONTAL-CORTEX OF FREELY MOVING RATS IN-VIVO, Journal of neurochemistry, 66(5), 1996, pp. 2209-2212
Authors:
MILLAN MJ
PEGLION JL
VIAN J
RIVET JM
BROCCO M
GOBERT A
NEWMANTANCREDI A
DACQUET C
BERVOETS K
GIRARDON S
JACQUES V
CHAPUT C
AUDINOT V
Citation: Mj. Millan et al., FUNCTIONAL CORRELATES OF DOPAMINE D-3 RECEPTOR ACTIVATION IN THE RAT IN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .1. ACTIVATION OF POSTSYNAPTIC D-3, RECEPTORS MEDIATES HYPOTHERMIA, WHEREAS BLOCKADE OF D-2 RECEPTORS ELICITS PROLACTIN SECRETION AND CATALEPSY()), The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 885-898
Authors:
GOBERT A
RIVET JM
AUDINOT V
CISTARELLI L
SPEDDING M
VIAN J
PEGLION JL
MILLAN MJ
Citation: A. Gobert et al., FUNCTIONAL CORRELATES OF DOPAMINE D-3, RECEPTOR ACTIVATION IN THE RATIN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .2. BOTH D-2 AND SILENT D-3 AUTORECEPTORS CONTROL SYNTHESIS AND RELEASEIN MESOLIMBIC, MESOCORTICAL AND NIGROSTRIATAL PATHWAYS()), The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 899-913
Authors:
GOBERT A
LEJEUNE F
RIVET JM
AUDINOT V
NEWMANTANCREDI A
MILLAN MJ
Citation: A. Gobert et al., MODULATION OF THE ACTIVITY OF CENTRAL SEROTONINERGIC NEURONS BY NOVELSEROTONIN(1A) RECEPTOR AGONISTS AND ANTAGONISTS - A COMPARISON TO ADRENERGIC AND DOPAMINERGIC-NEURONS IN RATS, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1032-1046
Authors:
MILLAN MJ
RIVET JM
AUDINOT V
GOBERT A
LEJEUNE F
BROCCO M
NEWMANTANCREDI A
MAURELREMY S
BERVOETS K
Citation: Mj. Millan et al., ANTAGONIST PROPERTIES OF LY-165,163 AT PRESYNAPTIC AND POSTSYNAPTIC DOPAMINE D-2, D-3, AND D-1 RECEPTORS - MODULATION OF AGONIST ACTIONS AT5-HT1A RECEPTORS IN-VIVO, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1418-1427
Authors:
SCHREIBER R
BROCCO M
AUDINOT V
GOBERT A
VEIGA S
MILLAN MJ
Citation: R. Schreiber et al., (1-(2,5-DIMETHOXY-4 IODOPHENYL)-2-AMINOPROPANE)-INDUCED HEAD-TWITCHESIN THE RAT ARE MEDIATED BY 5-HYDROXYTRYPTAMINE (5-HT)(2A) RECEPTORS -MODULATION BY NOVEL 5-HT2A 2C ANTAGONISTS, D-1 ANTAGONISTS AND 5-HT1AAGONISTS/, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 101-112
Authors:
PEGLION JL
CANTON H
BERVOETS K
AUDINOT V
BROCCO M
GOBERT A
LEMAROUILLEGIRARDON S
MILLAN MJ
Citation: Jl. Peglion et al., CHARACTERIZATION OF POTENT AND SELECTIVE ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS IN A SERIES OF N4-SUBSTITUTED ARYLPIPERAZINES, Journal of medicinal chemistry, 38(20), 1995, pp. 4044-4055
Authors:
MILLAN MJ
BERVOETS K
RIVET JM
WIDDOWSON P
RENOUARD A
LEMAROUILLEGIRARDON S
GOBERT A
Citation: Mj. Millan et al., MULTIPLE ALPHA-2-ADRENERGIC RECEPTOR SUBTYPES .2. EVIDENCE FOR A ROLEOF RAT R(ALPHA-2A), ADRENERGIC-RECEPTORS IN THE CONTROL OF NOCICEPTION, MOTOR BEHAVIOR AND HIPPOCAMPAL SYNTHESIS OF NORADRENALINE, The Journal of pharmacology and experimental therapeutics, 270(3), 1994, pp. 958-972
Authors:
MILLAN MJ
RIVET JM
GOBERT A
CANTON H
VEIGA S
BERVOETS K
Citation: Mj. Millan et al., 5-HT1A RECEPTORS AND THE TAIL-FLICK RESPONSE .6. INTRINSIC ALPHA(1A)-ADRENOCEPTOR ANTAGONIST PROPERTIES CAN MASK THE ACTIONS OF 5-HT1A RECEPTOR AGONISTS IN THE SPONTANEOUS TAIL-FLICK PARADIGM, The Journal of pharmacology and experimental therapeutics, 269(1), 1994, pp. 121-131
Authors:
MILLAN MJ
CANTON H
GOBERT A
LEJEUNE F
RIVET JM
BERVOETS K
BROCCO M
WIDDOWSON P
MENNINI T
AUDINOT V
HONORE P
RENOUARD A
LEMAROUILLEGIRARDON S
VERRIELE L
GRESSIER H
PEGLION JL
Citation: Mj. Millan et al., NOVEL BENZODIOXOPIPERAZINES ACTING AS ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS AND AS AGONISTS AT 5-HT1A AUTORECEPTORS - A COMPARATIVE PHARMACOLOGICAL CHARACTERIZATION WITH PROPOSED 5-HT1A ANTAGONISTS, The Journal of pharmacology and experimental therapeutics, 268(1), 1994, pp. 337-352
Authors:
SCHREIBER R
BROCCO M
GOBERT A
VEIGA S
MILLAN MJ
Citation: R. Schreiber et al., THE POTENT ACTIVITY OF THE 5-HT1A RECEPTOR AGONISTS, S-14506 AND S-14671, IN THE RAT FORCED SWIM TEST IS BLOCKED BY NOVEL 5-HT1A-RECEPTOR ANTAGONISTS, European journal of pharmacology, 271(2-3), 1994, pp. 537-541
Authors:
RIVET JM
AUDINOT V
GOBERT A
PEGLION JL
MILLAN MJ
Citation: Jm. Rivet et al., MODULATION OF MESOLIMBIC DOPAMINE RELEASE BY THE SELECTIVE DOPAMINE-D-3 RECEPTOR ANTAGONIST, (-S-14297()), European journal of pharmacology, 265(3), 1994, pp. 175-177